Old TB vaccine shows promise in fighting childhood diabetes
NCT ID NCT05866536
Summary
This study is testing whether repeat doses of the BCG vaccine, typically used against tuberculosis, can help children recently diagnosed with type 1 diabetes. Researchers want to see if the vaccine can improve long-term blood sugar control and help the body preserve its own insulin-making ability. About 100 children, aged 8 to under 18, will receive either the BCG vaccine or a placebo and be followed for five years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Immunobiology Labs CNY 149
RECRUITINGCharlestown, Massachusetts, 02129, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.